Posts Tagged ‘phase 3 trial’
Anti-CGRP Treatment Improves Prodromal Symptoms of Migraine
A new phase 3 clinical trial shows that ubrogepant, a CGRP receptor antagonist, alleviates photophobia, fatigue, neck pain, and other prodromal symptoms.
Read More